Lymphoma cytogenetics

Clinics in Laboratory Medicine

Volumn 31, Issue 4, 2011, Pages 725-761

  Dave, Bhavana J ^a   Nelson, Marilu ^a   Sanger, Warren G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cytogenetics; Diagnosis; Disease progression; Fluorescence in situ hybridization; Lymphoma; Microarray; Prognosis

Indexed keywords

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; B CELL LYMPHOMA; BURKITT LYMPHOMA; CELL TRANSFORMATION; CHROMOSOME DAMAGE; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLASSICAL HODGKIN LYMPHOMA; CLINICAL FEATURE; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GENETIC ASSOCIATION; HAIRY CELL LEUKEMIA; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; LYMPHOMA; LYMPHOPLASMACYTIC LYMPHOMA; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NK T CELL LYMPHOMA; NODAL MARGINAL ZONE LYMPHOMA; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; ONSET AGE; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; REVIEW; SEX RATIO; T CELL LEUKEMIA; T CELL LYMPHOMA; TISSUE CULTURE;

CHROMOSOME ABERRATIONS; CYTOGENETICS; DISEASE PROGRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 82355164266     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2011.08.001     Document Type: Review

References (205)

1. Manolov G., Manolova Y. Marker band in one chromosome 14 from Burkitt lymphomas. Nature 1972, 237:33-34.
2. Zech L., Haglund U., Nilsson K., et al. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 1976, 17:47-56.
3. Sanger W.G., Dave B.J., Bishop M.R. Cytogenetics. Malignant Lymphoma 2000, 91-103. Arnold, London. B. Hancock, K. Selby, K. MacLennan (Eds.).
4. Jaffe E.S., Harris N.L., Stein H., et al. Introduction and overview of the classification of the lymphoid neoplasms. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 158-166. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
5. Siebert R. Mature B- and T-cell Neoplasms and Hodgkin lymphoma. Cancer cytogenetics 2009, 297-374. John Wiley & Sons, Hoboken (NJ). 3rd edition. S. Heim, F. Mitelman (Eds.).
6. Banks P.M., Chan J., Cleary M.L., et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992, 16:637-640.
7. Mitelman F., Johansson B., Mertens F. Mitelman Database of Chromosome Aberrations in Cancer Accessed May, 2011. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
8. Swerdlow S.H., Campo E., Harris N.L., et al. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, IARC, Geneva (Switzerland). 4th edition.
9. Martin-Subero J.I., Kreuz M., Bibikova M., et al. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 2009, 113:2488-2497.
10. Bea S., Campo E. Secondary genomic alterations in non-Hodgkin's lymphomas: tumor-specific profiles with impact on clinical behavior. Haematologica 2008, 93:641-645.
11. Dave S.S., Wright G., Tan B., et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004, 351:2159-2169.
12. Dave S.S., Fu K., Wright G.W., et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006, 354:2431-2442.
13. Davies A.J., Rosenwald A., Wright G., et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol 2007, 136:286-293.
14. Monti S., Savage K.J., Kutok J.L., et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005, 105:1851-1861.
15. Rosenwald A., Wright G., Chan W.C., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:1937-1947.
16. Savage K.J., Monti S., Kutok J.L., et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003, 102:3871-3879.
17. Rosenwald A., Alizadeh A.A., Widhopf G., et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001, 194:1639-1647.
18. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997, 89:3909-3918. The Non-Hodgkin's Lymphoma Classification Project.
19. Morton L.M., Wang S.S., Devesa S.S., et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006, 107:265-276.
20. Savage K.J., Harris N.L., Vose J.M., et al. ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008, 111:5496-5504.
21. Schaffer L.G., Slovack M.L., Campbell L.J. ISCN 2009. An International System for Human Cytogenetic Nomenclature 2009, Karger S., Basel (Switzerland).
22. Dave B.J., Hess M.M., Pickering D.L., et al. Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma. Clin Cancer Res 1999, 5:1401-1409.
23. Dave B.J., Nelson M., Pickering D.L., et al. Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization. Cancer Genet Cytogenet 2002, 132:125-132.
24. Dave B.J., Weisenburger D.D., Higgins C.M., et al. Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults. Cancer Genet Cytogenet 2004, 153:115-121.
25. Muller-Harmelink H.K., Montserrat E., Catovsky D., et al. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 180-182. IARC, Geneva (Switzerland). S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
26. Dicker F., Schnittger S., Haferlach T., et al. Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression. Blood 2006, 108:3152-3160.
27. Dohner H., Stilgenbauer S., Benner A., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000, 343:1910-1916.
28. Haferlach C., Dicker F., Schnittger S., et al. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping. Leukemia 2007, 21:2442-2451.
29. Dohner H., Pohl S., Bulgay-Morschel M., et al. Trisomy 12 in chronic lymphoid leukemias-a metaphase and interphase cytogenetic analysis. Leukemia 1993, 7:516-520.
30. Dohner H., Stilgenbauer S., James M.R., et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997, 89:2516-2522.
31. Stilgenbauer S., Lichter P., Dohner H. Genetic features of B-cell chronic lymphocytic leukemia. Rev Clin Exp Hematol 2000, 4:48-72.
32. Dohner H., Stilgenbauer S., Dohner K., et al. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 1999, 77:266-281.
33. Sellmann L., Gesk S., Walter C., et al. Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia. Br J Haematol 2007, 138:217-220.
34. Sen F., Lai R., Albitar M. Chronic lymphocytic leukemia with t14;18 and trisomy 12. Arch Pathol Lab Med 2002, 126:1543-1546.
35. Martin-Subero J.I., Ibbotson R., Klapper W., et al. A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t14;19q32;q13 or variant BCL3-translocation. Leukemia 2007, 21:1532-1544.
36. Pospisilova H., Baens M., Michaux L., et al. Interstitial del14q involving IGH: a novel recurrent aberration in B-NHL. Leukemia 2007, 21:2079-2083.
37. Stilgenbauer S., Leupolt E., Ohl S., et al. Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res 1995, 55:3475-3477.
38. Ouillette P., Erba H., Kujawski L., et al. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 2008, 68:1012-1021.
39. Austen B., Skowronska A., Baker C., et al. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. J Clin Oncol 2007, 25:5448-5457.
40. Mayr C., Speicher M.R., Kofler D.M., et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 2006, 107:742-751.
41. Bea S., Lopez-Guillermo A., Ribas M., et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma Richter's syndrome. Am J Pathol 2002, 161:957-968.
42. Campo E., Catovsky D., Montserrat E., et al. B-cell prolymphocytic leukaemia. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 183-184. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
43. Schlette E., Bueso-Ramos C., Giles F., et al. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol 2001, 115:571-581.
44. Brito-Babapulle V., Pittman S., Melo J.V., et al. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia. Hematol Pathol 1987, 1:27-33.
45. Ruchlemer R., Parry-Jones N., Brito-Babapulle V., et al. B-prolymphocytic leukaemia with t11;14 revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia. Br J Haematol 2004, 125:330-336.
46. Berger F., Felman P., Thieblemont C., et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 2000, 95:1950-1956.
47. Issacson P.G., Piris M.A., Berger F., et al. Splenic B-cell marginal zone lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 185-187. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
48. Sole F., Salido M., Espinet B., et al. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Haematologica 2001, 86:71-77.
49. Callet-Bauchu E., Baseggio L., Felman P., et al. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases. Leukemia 2005, 19:1818-1823.
50. Gazzo S., Baseggio L., Coignet L., et al. Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma. Haematologica 2003, 88:31-38.
51. Corcoran M.M., Mould S.J., Orchard J.A., et al. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene 1999, 18:6271-6277.
52. Brito-Babapulle V., Gruszka-Westwood A.M., Platt G., et al. Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia. Haematologica 2002, 87:357-362.
53. Algara P., Mateo M.S., Sanchez-Beato M., et al. Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 2002, 99:1299-1304.
54. Foucar K., Falini B., Catovsky D., et al. Hairy cell leukaemia. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 188-190. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
55. Sambani C., Trafalis D.T., Mitsoulis-Mentzikoff C., et al. Clonal chromosome rearrangements in hairy cell leukemia: personal experience and review of literature. Cancer Genet Cytogenet 2001, 129:138-144.
56. Nessling M., Solinas-Toldo S., Lichter P., et al. Genomic imbalances are rare in hairy cell leukemia. Genes Chromosomes Cancer 1999, 26:182-183.
57. Ostergaard M., Lindbjerg A.C., Pedersen B., et al. Recurrent imbalances involving chromosome 5 and 7q22-q35 in hairy cell leukemia: a comparative genomic hybridization study. Genes Chromosomes Cancer 2001, 30:218-219.
58. Swerdlow S.H., Berger F., Pileri S.A. Lymphoplasmacytic lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 194-195. IARC, Geneva (Switzerland). E.S. Jaffe, S.A. Pileri, H. Stein (Eds.).
59. Iida S., Rao P.H., Nallasivam P., et al. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 1996, 88:4110-4117.
60. Cook J.R., Aguilera N.I., Reshmi-Skarja S., et al. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t9;14. Hum Pathol 2004, 35:447-454.
61. Baro C., Salido M., Domingo A., et al. Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma. Haematologica 2006, 91:1289-1291.
62. Schop R.F., Kuehl W.M., Van Wier S.A., et al. Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood 2002, 100:2996-3001.
63. Issacson P.G., Chott A., Nakamura S., et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue MALT lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 214-217. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
64. Dierlamm J., Baens M., Stefanova-Ouzounova M., et al. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood 2000, 96:2215-2218.
65. Akagi T., Motegi M., Tamura A., et al. A novel gene, MALT1 at 18q21, is involved in t(11;18)(q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999, 18:5785-5794.
66. Vega F., Medeiros L.J. Chromosomal translocations involved in non-Hodgkin lymphomas. Arch Pathol Lab Med 2003, 127:1148-1160.
67. Horsman D., Gascoyne R., Klasa R., et al. t(11;18)(q21;q21.1): a recurring translocation in lymphomas of mucosa-associated lymphoid tissue MALT?. Genes Chromosomes Cancer 1992, 4:183-187.
68. Ott G., Katzenberger T., Greiner A., et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue MALT- type. Cancer Res 1997, 57:3944-3948.
69. Barth T.F., Bentz M., Leithauser F., et al. Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 2001, 31:316-325.
70. Streubel B., Simonitsch-Klupp I., Mullauer L., et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004, 18:1722-1726.
71. Ye H., Gong L., Liu H., et al. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J Pathol 2005, 205:293-301.
72. Streubel B., Vinatzer U., Lamprecht A., et al. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005, 19:652-658.
73. Streubel B., Lamprecht A., Dierlamm J., et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003, 101:2335-2339.
74. Sanchez-Izquierdo D., Buchonnet G., Siebert R., et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 2003, 101:4539-4546.
75. Willis T.G., Jadayel D.M., Du M.Q., et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999, 96:35-45.
76. Zhang Q., Siebert R., Yan M., et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 1999, 22:63-68.
77. Chuang S.S., Liu H., Martin-Subero J.I., et al. Pulmonary mucosa-associated lymphoid tissue lymphoma with strong nuclear B-cell CLL/lymphoma BCL10 expression and novel translocation t(1;2)(p22;p12)/immunoglobulin kappa chain-BCL10. J Clin Pathol 2007, 60:727-728.
78. Zhou Y., Ye H., Martin-Subero J.I., et al. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21). Br J Haematol 2006, 133:35-42.
79. Zhou Y., Ye H., Martin-Subero J.I., et al. The pattern of genomic gains in salivary gland MALT lymphomas. Haematologica 2007, 92:921-927.
80. Honma K., Tsuzuki S., Nakagawa M., et al. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosomes Cancer 2008, 47:1-7.
81. Nakamura S., Ye H., Bacon C.M., et al. Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation. Gut 2007, 56:1358-1363.
82. Rizzo K.A., Streubel B., Pittaluga S., et al. Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol 2010, 23:866-873.
83. Harris N.L., Swerdlow S.H., Jaffe E.S., et al. Follicular lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 220-226. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
84. Biagi J.J., Seymour J.F. Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood 2002, 99:4265-4275.
85. Johansson B., Mertens F., Mitelman F. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 1995, 86:3905-3914.
86. Swerdlow S.H. Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia. Am J Clin Pathol 2004, 122(Suppl):S98-S109. S98-109.
87. Tsujimoto Y., Finger L.R., Yunis J., et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984, 226:1097-1099.
88. Zinkel S., Gross A., Yang E. BCL2 family in DNA damage and cell cycle control. Cell Death Differ 2006, 13:1351-1359.
89. Letai A.G. Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 2008, 8:121-132.
90. Albinger-Hegyi A., Hochreutener B., Abdou M.T., et al. High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection. Am J Pathol 2002, 160:823-832.
91. d'Amore F., Chan E., Iqbal J., et al. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution. Clin Cancer Res 2008, 14:7180-7187.
92. Hoglund M., Sehn L., Connors J.M., et al. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer 2004, 39:195-204.
93. Horsman D.E., Okamoto I., Ludkovski O., et al. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br J Haematol 2003, 120:424-433.
94. Katzenberger T., Ott G., Klein T., et al. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. Am J Pathol 2004, 165:481-490.
95. Jardin F., Ruminy P., Bastard C., et al. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis. Pathol Biol [Paris] 2007, 55:73-83.
96. Pasqualucci L., Bereschenko O., Niu H., et al. Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. Leuk Lymphoma 2003, 44(Suppl 3):S5-S12. S5-12.
97. Butler M.P., Iida S., Capello D., et al. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma. Cancer Res 2002, 62:4089-4094.
98. Bosga-Bouwer A.G., Haralambieva E., Booman M., et al. BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B. Genes Chromosomes Cancer 2005, 44:301-304.
99. Gu K., Fu K., Jain S., et al. t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region. Mod Pathol 2009, 22:1251-1257.
100. Tilly H., Rossi A., Stamatoullas A., et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994, 84:1043-1049.
101. Schwaenen C., Viardot A., Berger H., et al. Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Cancer 2009, 48:39-54.
102. Bosga-Bouwer A.G., van den Berg A., Haralambieva E., et al. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?. Hum Pathol 2006, 37:528-533.
103. Christie L., Kernohan N., Levison D., et al. C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: an adverse prognostic indicator?. Leuk Lymphoma 2008, 49:470-476.
104. Li J.Y., Gaillard F., Moreau A., et al. Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol 1999, 154:1449-1452.
105. Rosenberg C.L., Wong E., Petty E.M., et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 1991, 88:9638-9642.
106. Weisenburger D.D., Vose J.M., Greiner T.C., et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol 2000, 64:190-196.
107. Komatsu H., Yoshida K., Seto M., et al. Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation. Br J Haematol 1993, 85:427-429.
108. Wlodarska I., Meeus P., Stul M., et al. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma. Leukemia 2004, 18:1705-1710.
109. Gesk S., Klapper W., Martin-Subero J.I., et al. A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. Blood 2006, 108:1109-1110.
110. Herens C., Lambert F., Quintanilla-Martinez L., et al. Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression. Blood 2008, 111:1745-1746.
111. Michaux L., Wlodarska I., Theate I., et al. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome. Ann Hematol 2004, 83:578-583.
112. Rubio-Moscardo F., Climent J., Siebert R., et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood 2005, 105:4445-4454.
113. Vater I., Wagner F., Kreuz M., et al. GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma. Br J Haematol 2009, 144:317-331.
114. Salaverria I., Zettl A., Bea S., et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol 2007, 25:1216-1222.
115. Sander S., Bullinger L., Leupolt E., et al. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations. Haematologica 2008, 93:680-687.
116. Stein H., Warnke R.A., Chan W.C., et al. Diffuse large B-cell lymphoma, not otherwise specified. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 233-237. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
117. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
118. Lenz G., Nagel I., Siebert R., et al. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med 2007, 19;204:633-643.
119. Bastard C., Deweindt C., Kerckaert J.P., et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 1994, 83:2423-2427.
120. Offit K., Lo C.F., Louie D.C., et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 1994, 331:74-80.
121. Ye B.H., Rao P.H., Chaganti R.S., et al. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 1993, 53:2732-2735.
122. Hummel M., Bentink S., Berger H., et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006, 354:2419-2430.
123. Schlegelberger B., Zwingers T., Harder L., et al. Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Blood 1999, 94:3114-3120. Kiel-Wien-Lymphoma Study Group.
124. Iqbal J., Sanger W.G., Horsman D.E., et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol 2004, 165:159-166.
125. Ueda C., Nishikori M., Kitawaki T., et al. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma. Int J Hematol 2004, 79:52-54.
126. Aukema S.M., Siebert R., Schuuring E., et al. Double-hit B-cell lymphomas. Blood 2011, 117:2319-2331.
127. Cigudosa J.C., Parsa N.Z., Louie D.C., et al. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer 1999, 25:123-133.
128. Leoncini L., Raphael M., Stein H., et al. Burkitt lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 262-264. IARC, Geneva (Switzerland). S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
129. Bellan C., Stefano L., Giulia de F., et al. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach. Hematol Oncol 2010, 28:53-56.
130. Boerma E.G., Siebert R., Kluin P.M., et al. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of today's knowledge. Leukemia 2009, 23:225-234.
131. Sanchez-Beato M., Saez A.I., Navas I.C., et al. Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27. Am J Pathol 2001, 159:205-213.
132. Lindstrom M.S., Wiman K.G. Role of genetic and epigenetic changes in Burkitt lymphoma. Semin Cancer Biol 2002, 12:381-387.
133. Nelson M., Perkins S.L., Dave B.J., et al. An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961. Br J Haematol 2010, 148:600-610.
134. Bertrand P., Bastard C., Maingonnat C., et al. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas. Leukemia 2007, 21:515-523.
135. Sonoki T., Tatetsu H., Nagasaki A., et al. Molecular cloning of translocation breakpoint from der(8)t(3;8)(q27;q24) defines juxtaposition of downstream of C-MYC and upstream of BCL6. Int J Hematol 2007, 86:196-198.
136. Jaffe E.S., Gaulard P., Ralfkiaer E., et al. Subcutaneous panniculitis-like T-cell lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 294-295. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
137. Vose J., Armitage J., Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008, 26:4124-4130.
138. Catovsky D., Muller-Harmelink H.K., Ralfkiaer E. T-cell prolymphocytic leukemia. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 270-271. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
139. Brito-Babapulle V., Catovsky D. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. Cancer Genet Cytogenet 1991, 55:1-9.
140. Maljaei S.H., Brito-Babapulle V., Hiorns L.R., et al. Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization. Cancer Genet Cytogenet 1998, 103:110-116.
141. Pekarsky Y., Hallas C., Isobe M., et al. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proc Natl Acad Sci USA 1999, 96:2949-2951.
142. Stern M.H., Soulier J., Rosenzwajg M., et al. MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. Oncogene 1993, 8:2475-2483.
143. Stilgenbauer S., Schaffner C., Litterst A., et al. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 1997, 3:1155-1159.
144. Costa D., Queralt R., Aymerich M., et al. High levels of chromosomal imbalances in typical and small-cell variants of T-cell prolymphocytic leukemia. Cancer Genet Cytogenet 2003, 147:36-43.
145. Hetet G., Dastot H., Baens M., et al. Recurrent molecular deletion of the 12p13 region, centromeric to ETV6/TEL, in T-cell prolymphocytic leukemia. Hematol J 2000, 1:42-47.
146. Durig J., Bug S., Klein-Hitpass L., et al. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia 2007, 21:2153-2163.
147. Herling M., Patel K.A., Teitell M.A., et al. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood 2008, 111:328-337.
148. Oshima K., Jaffe E.S., Kikuchi M. Adult T-cell leukaemia/lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 281-284. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
149. Tsukasaki K., Krebs J., Nagai K., et al. Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. Blood 2001, 97:3875-3881.
150. Oshiro A., Tagawa H., Ohshima K., et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood 2006, 107:4500-4507.
151. Chan J.K.C., Quintanilla-Martinez L., Ferry J.A., et al. Extranodal NK/T-cell lymphoma, nasal type. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 285-288. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
152. Siu L.L., Wong K.F., Chan J.K., et al. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations. Am J Pathol 1999, 155:1419-1425.
153. Tien H.F., Su I.J., Tang J.L., et al. Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas. Br J Haematol 1997, 97:621-625.
154. Wong K.F., Zhang Y.M., Chan J.K. Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia-is there a consistent pattern?. Leuk Lymphoma 1999, 34:241-250.
155. Nakashima Y., Tagawa H., Suzuki R., et al. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type. Genes Chromosomes Cancer 2005, 44:247-255.
156. Issacson P.G., Chott A., Ott G., Stein H. Enteropathy-associated T-cell lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 289-291. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
157. Zettl A., Ott G., Makulik A., et al. Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol 2002, 161:1635-1645.
158. Baumgartner A.K., Zettl A., Chott A., et al. High frequency of genetic aberrations in enteropathy-type T-cell lymphoma. Lab Invest 2003, 83:1509-1516.
159. Deleeuw R.J., Zettl A., Klinker E., et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 2007, 132:1902-1911.
160. Almire C., Bertrand P., Ruminy P., et al. PVRL2 is translocated to the TRA locus in t(14;19)(q11;q13)-positive peripheral T-cell lymphomas. Genes Chromosomes Cancer 2007, 46:1011-1018.
161. Leich E., Haralambieva E., Zettl A., et al. Tissue microarray-based screening for chromosomal breakpoints affecting the T-cell receptor gene loci in mature T-cell lymphomas. J Pathol 2007, 213:99-105.
162. Streubel B., Vinatzer U., Willheim M., et al. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006, 20:313-318.
163. Nelson M., Horsman D.E., Weisenburger D.D., et al. Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma. Br J Haematol 2008, 141:461-469.
164. Schlegelberger B., Himmler A., Bartles H., et al. Recurrent chromosome abnormalities in peripheral T-cell lymphomas. Cancer Genet Cytogenet 1994, 78:15-22.
165. Schlegelberger B., Himmler A., Godde E., et al. Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 1994, 83:505-511.
166. Lepretre S., Buchonnet G., Stamatoullas A., et al. Chromosome abnormalities in peripheral T-cell lymphoma. Cancer Genet Cytogenet 2000, 117:71-79.
167. Zettl A., Rudiger T., Konrad M.A., et al. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 2004, 164:1837-1848.
168. Thorns C., Bastian B., Pinkel D., et al. Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: a matrix-based CGH approach. Genes Chromosomes Cancer 2007, 46:37-44.
169. de L.L., Rickman D.S., Thielen C., et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma AITL and follicular helper T TFH cells. Blood 2007, 109:4952-4963.
170. Piccaluga P.P., Agostinelli C., Califano A., et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 2007, 117:823-834.
171. Dogan A., Gaulard P., Jaffe E.S., et al. Angioimmunoblastic T-cell Lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 309-311. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
172. Schlegelberger B., Zhang Y., Weber-Matthiesen K., et al. Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined interphase and metaphase cytogenetics. Blood 1994, 84:2640-2648.
173. Dogan A., Attygalle A.D., Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol 2003, 121:681-691.
174. Gesk S., Martin-Subero J.I., Harder L., et al. Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci. Leukemia 2003, 17:738-745.
175. Schlegelberger B., Zwingers T., Hohenadel K., et al. Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. J Clin Oncol 1996, 14:593-599.
176. Stein H., Foss H.D., Durkop H., et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000, 96:3681-3695.
177. Benharroch D., Meguerian-Bedoyan Z., Lamant L., et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998, 91:2076-2084.
178. Falini B., Pulford K., Pucciarini A., et al. Lymphomas expressing ALK fusion proteins other than NPM-ALK. Blood 1999, 94:3509-3515.
179. Kinney M.C., Higgins R.A., Medina E.A. Anaplastic large cell lymphoma: twenty-five years of discovery. Arch Pathol Lab Med 2011, 135:19-43.
180. Foss H.D., Anagnostopoulos I., Araujo I., et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996, 88:4005-4011.
181. Delsol G., Falini B., Muller-Harmelink H.K., et al. Anaplastic large cell lymphoma ALCL, ALK-positive. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 312-316. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
182. Duyster J., Bai R.Y., Morris S.W. Translocations involving anaplastic lymphoma kinase ALK. Oncogene 2001, 20:5623-5637.
183. Salaverria I., Bea S., Lopez-Guillermo A., et al. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Br J Haematol 2008, 140:516-526.
184. Weisenburger D.D., Gordon B.G., Vose J.M., et al. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood 1996, 87:3860-3868.
185. Mason D.Y., Harris N.L., Delsol G., et al. Anaplastic large cell lymphoma, ALK-negative. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 317-319. IARC, Geneva (Switzerland). 4th edition. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
186. ten Berge R.L., de Bruin P.C., Oudejans J.J., et al. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified. Histopathology 2003, 43:462-469.
187. Gascoyne R.D., Aoun P., Wu D., et al. Prognostic significance of anaplastic lymphoma kinase ALK protein expression in adults with anaplastic large cell lymphoma. Blood 1999, 93:3913-3921.
188. Anagnostopoulos I., Hansmann M.L., Franssila K., et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 2000, 96:1889-1899.
189. Diehl V., Sextro M., Franklin J., et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol 1999, 17:776-783.
190. Nogova L., Reineke T., Brillant C., et al. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol 2008, 26:434-439.
191. Atayar C., Kok K., Kluiver J., et al. BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV. Hum Pathol 2006, 37:675-683.
192. Renne C., Martin-Subero J.I., Hansmann M.L., et al. Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition. J Mol Diagn 2005, 7:352-356.
193. Wlodarska I., Nooyen P., Maes B., et al. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood 2003, 101:706-710.
194. Chui D.T., Hammond D., Baird M., et al. Classical Hodgkin lymphoma is associated with frequent gains of 17q. Genes Chromosomes Cancer 2003, 38:126-136.
195. Stein H., Delsol G., Pileri S.A., et al. Classical Hodgkin lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 326-329. IARC, Geneva (Switzerland). S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
196. Sarris A., Jhanwar S.C., Cabanillas F. Cytogenetics of Hodgkin's disease. Hodgkin's disease 1999, 195. Lippincott Williams & Willkins, Philadelphia. P. Mauch, J.O. Armitage, V. Diehl (Eds.).
197. Nakamura N., Ohshima K., Abe M., et al. Demonstration of chimeric DNA of bcl-2 and immunoglobulin heavy chain in follicular lymphoma and subsequent Hodgkin lymphoma from the same patient. J Clin Exp Hematop 2007, 47:9-13.
198. Martin-Subero J.I., Klapper W., Sotnikova A., et al. Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Cancer Res 2006, 66:10332-10338.
199. Szymanowska N., Klapper W., Gesk S., et al. BCL2 and BCL3 are recurrent translocation partners of the IGH locus. Cancer Genet Cytogenet 2008, 186:110-114.
200. Joos S., Kupper M., Ohl S., et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 2000, 60:549-552.
201. Schlegelberger B., Weber-Matthiesen K., Himmler A., et al. Cytogenetic findings and results of combined immunophenotyping and karyotyping in Hodgkin's disease. Leukemia 1994, 8:72-80.
202. Weber-Matthiesen K., Deerberg J., Poetsch M., et al. Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 1995, 86:1464-1468.
203. Atkin N.B. Cytogenetics of Hodgkin's disease. Cytogenet Cell Genet 1998, 80:23-27.
204. Schouten H.C., Sanger W.G., Armitage J.O. Chromosomal abnormalities in malignant lymphoma and Hodgkin's disease: a review. Leuk Lymphoma 1991, 5:93-100.
205. Falzetti D., Crescenzi B., Matteuci C., et al. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease. Haematologica 1999, 84:298-305.